Abstract Details

Title Features, Functionalities, and the Future of Commercial Pain Applications

Topic Pain

Presentation(s) P1 - Poster Session 1 (9:00 AM-5:00 PM)

Poster/Presentation
Number 444

Objective We aimed to assess the characteristics of the pain application (app) marketplace and determine improvements to mobile health (mHealth) that could assist patients with pain disorders in obtaining more accessible care.

Background During the COVID-19 pandemic, complementary and integrative therapies delivered via mHealth technologies have become more popular due to their accessibility. As more users are downloading apps to address health concerns, it is important to analyze the ever-growing marketplace’s features and limitations.

Design/Methods After searching the iOS and Google Play Stores for commercially available pain apps that met pre-specified search criteria, trained app raters entered 47 apps into the Mobile-Health Index and Navigation Database (MIND) published by the Division of Digital Psychiatry at BIDMC. Through a 105-question objective rating framework, each app was evaluated for its accessibility, privacy, cost, functionalities, features, and clinical foundations. The data was compared with a control group of non-pain apps—matched for platform and cost—to examine the traits of pain apps in contrast with the rest of the marketplace.

Results The top features were 44.7% (21/47) offered symptom tracking, 34.0% (16/47) offered medication tracking, and 42.6% (20/47) offered physical health exercises. Just 2.13% (1/47) of apps offered HIPAA privacy protections or had a crisis management feature. Additionally, only 10.64% (5/47) of pain apps were supported by efficacy studies.

Conclusions Commercially available pain apps are typically used to record pain episodes or document medications. However, the lack of privacy, crisis management, and efficacy studies may be preventing their clinical implementation.

Authors/Disclosures
PRESENTER	No disclosure on file
Mia Soviero	Miss Soviero has nothing to disclose.
	No disclosure on file
Quazi I. Hossain	Mr. Hossain has nothing to disclose.
Leslie Yao	Ms. Yao has nothing to disclose.
Ananya Sahu, Other	Ms. Sahu has nothing to disclose.
	No disclosure on file
	No disclosure on file
Mia T. Minen, MD, FAAN (NYULMC Neurology)	The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .

��ɫ��

��ɫ��